Get notified when VREX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Goodwill Impairment (new) — The $93.9M goodwill impairment charge recorded in Q3 FY2025 (Medical reporting unit) remains disclosed; no new impairment this quarter, but the prior-year event is carried forward as a standing risk.
Varex agrees to $18.90/share Teledyne acquisition; Q3 revenue +3.7% to $210.5M, net income $15.9M
Filed August 10, 2026 · Period ending July 3, 2026 · Compared to 10-Q Aug 7, 2025 · ~2 min read
Key Changes
-
high
Definitive merger agreement signed August 10, 2026, with Teledyne Technologies for $18.90 cash per share; closing expected early 2027 subject to shareholder vote, antitrust clearance (U.S., China, other jurisdictions), and customary conditions. Varex may owe $25.3M termination fee under certain circumstances.
Notes: Proposed Teledyne acquisition view on EDGAR → -
high
Operating income swung from -$80.7M loss to $22.8M profit YoY, while net income reached $15.9M ($0.37 diluted EPS). Revenue rose 3.7% to $210.5M, though the prior-year quarter contained an extra week, making direct volume comparisons difficult.
Key Financials / MD&A view on EDGAR → -
high
Debt refinanced: redeemed all $368M of 7.875% Senior Secured Notes in March 2026 (paying 2% premium, $9.2M loss.
Notes: Debt refinancing and extinguishment view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FGBI 10-Q) is open in full — no account needed.
Partner
Trade VREX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 18, 2026 · How we verify